Managing patients with a failed kidney transplant: How can we do better?

Current Opinion in Nephrology and Hypertension

Volumn 20, Issue 6, 2011, Pages 616-621

  Gill, John S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

chronic kidney disease; immunosuppression; infection

Indexed keywords

ANTIBODY; CALCINEURIN INHIBITOR; CORTICOSTEROID; LEUKOCYTE ANTIGEN;

ALLOGRAFT; ANTIBODY BLOOD LEVEL; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CLINICAL DECISION MAKING; DIALYSIS; DRUG TOLERANCE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MORTALITY; NEPHRECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETRANSPLANTATION; REVIEW; RISK ASSESSMENT; SEPSIS;

CANADA; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; NEPHRECTOMY; RENAL DIALYSIS; REOPERATION; TIME FACTORS; TREATMENT FAILURE;

EID: 80054772193     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32834bd792     Document Type: Review

References (36)

1. Gill JS, Abichandani R, Kausz AT, Pereira BJ. Mortality after kidney transplant failure: the impact of nonimmunologic factors. Kidney Int 2002; 62:1875-1883. (Pubitemid 35286299)
2. Knoll G, Muirhead N, Trpeski L, et al. Patient survival following renal transplant failure in Canada. Am J Transplant 2005; 5:1719-1724. (Pubitemid 40910455)
3. Kaplan B, Meier-Kriesche HU. Death after graft loss: an important late study endpoint in kidney transplantation. Am J Transplant 2002; 2:970-974. (Pubitemid 36330228)
4. USRDS. Annual data report: atlas of end stage renal disease in the United States. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease; 2010.
5. Ojo A, Wolfe R, Agodoa L, et al. Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation. Transplantation 1998; 66:1651-1659.
6. Magee JC, Barr ML, Basadonna GP, et al. Repeat organ transplantation in the United States, 1996-2005. Am J Transplant 2007; 7 (5 Pt 2):1424-1433. (Pubitemid 46606945)
7. Gill JS, Rose C, Pereira BJ, Tonelli M. The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients. Kidney Int 2007; 71:442-447.
8. USRDS. Annual data report: atlas of end stage renal disease in the United States. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease; 2008.
9. Johnston O, Zalunardo N, Rose C, Gill JS. Prevention of sepsis during the transition to dialysis may improve the survival of transplant failure patients. J Am Soc Nephrol 2007; 18:1331-1337. (Pubitemid 46536920)
10. Smak Gregoor PJ, Zietse R, van Saase JL, et al. Immunosuppression should be stopped in patients with renal allograft failure. Clin Transplant 2001; 15:397-401. (Pubitemid 33094991)
11. Lopez-Gomez JM, Perez-Flores I, Jofre R, et al. Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance. J Am Soc Nephrol 2004; 15:2494-2501. (Pubitemid 39159351)
12. Gill J, Abichandani R, Khan S, et al. Opportunities to improve the care of patients with kidney transplant failure. Kidney Int 2002; 61:2193-2198.
13. Jassal SV, Lok CE, Walele A, Bargman JM. Continued transplant immuno-suppression may prolong survival after return to peritoneal dialysis: results of a decision analysis. Am J Kidney Dis 2002; 40:178-183. (Pubitemid 34701226)
14. Burn DJ, Bates D. Neurology and the kidney. J Neurol Neurosurg Psychiatry 1998; 65:810-821. (Pubitemid 128710419)
15. Johnston O, Rose C, Landsberg D, et al. Nephrectomy after transplant failure: current practice and outcomes. Am J Transplant 2007; 7:1961-1967. (Pubitemid 47037994)
16. Solid CA, Foley RN, Gill JS, et al. Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants. Kidney Int 2007; 71:425-430.
17. Sumrani N, Delaney V, Hong JH, et al. The influence of nephrectomy of the primary allograft on retransplant graft outcome in the cyclosporine era. Transplantation 1992; 53:52-55.
18. Douzdjian V, Rice JC, Carson RW, et al. Renal retransplants: effect of primary allograft nephrectomy on early function, acute rejection and outcome. Clin Transplant 1996; 10:203-208. (Pubitemid 26091834)
19. Gourlay W, Patterson R, Gill J. Influence of transplant nephrectomy on panel reactive antibody titer and waiting time for second kidney transplants. Transplantation 1999; 67:S169.
20. Knight MG, Tiong HY, Li J, et al. Transplant nephrectomy after allograft failure is associated with allosensitization. Urology 2011; 78:314-318.
21. Khakhar AK, Shahinian VB, House AA, et al. The impact of allograft nephrectomy on percentage panel reactive antibody and clinical outcome. Transplant Proc 2003; 35:862-863. (Pubitemid 36338189)
22. Sener A, Khakhar AK, Nguan CY, et al. Early but not late allograft nephrectomy reduces allosensitization after transplant failure. Can Urol Assoc J 2011; 1:1-6.
23. Bharmal A, Moore RB, Todd GT, Cockfield S, Campbell P. Transplant nephrectomy is associated with increased sensitization. Edmonton: Canadian Society of Nephrology; 2009.
24. Schleicher C, Wolters H, Kebschull L, et al. Impact of failed allograft nephrectomy on initial function and graft survival after kidney retransplantation. Transpl Int 24:284-291.
25. Yagmurdur MC, Emiroglu R, Ayvaz I, et al. The effect of graft nephrectomy on long-term graft function and survival in kidney retransplantation. Transplant Proc 2005; 37:2957-2961. (Pubitemid 41435586)
26. Abouljoud MS, Deierhoi MH, Hudson SL, Diethelm AG. Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy. Transplantation 1995; 60:138-144.
27. Ahmad N, Ahmed K, Mamode N. Does nephrectomy of failed allograft influence graft survival after re-transplantation? Nephrol Dial Transplant 2009; 24:639-642.
28. Lair D, Coupel S, Giral M, et al. The effect of a first kidney transplant on a subsequent transplant outcome: an experimental and clinical study. Kidney Int 2005; 67:2368-2375. (Pubitemid 41623399)
29. Goldfarb-Rumyantzev AS, Hurdle JF, Baird BC, et al. The role of preemptive re-transplant in graft and recipient outcome. Nephrol Dial Transplant 2006; 21:1355-1364.
30. Thomas PP, Jacob CK, Kirubakaran MG, et al. Indication for routine allograft nephrectomy in cases of irreversible rejection. Transplantation 1989; 48:155. (Pubitemid 19194062)
31. Hansen BL, Rohr N, Svendsen V, Birkeland SA. Graft failure and graft nephrectomy without severe complications. Nephrol Dial Transplant 1987; 2:189-190. (Pubitemid 18004804)
32. Secin FP, Rovegno AR, del Rosario Brunet M, et al. Cumulative incidence, indications, morbidity and mortality of transplant nephrectomy and the most appropriate time for graft removal: only nonfunctioning transplants that cause intractable complications should be excised. J Urol 2003; 169:1242-1246. (Pubitemid 36323759)
33. Ayus JC, Achinger SG, Lee S, et al. Transplant nephrectomy improves survival following a failed renal allograft. J Am Soc Nephrol 2009; 21: 374-380.
34. Gill JS, Abichandani R, Khan S, et al. Opportunities to improve the care of patients with kidney transplant failure. Kidney Int 2002; 61:2193-2200. (Pubitemid 34539337)
35. Perl J, Hasan O, Bargman JM, et al. Impact of dialysis modality on survival after kidney transplant failure. Clin J Am Soc Nephrol 6:582-590.
36. Meier-Kriesche HU, Scornik JC, Susskind B, et al. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation 2009; 88:23-29.